| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 85,777 | 84,149 | 83,176 | 82,129 | | Cost of Revenue | 17,299 | 15,787 | 17,547 | 158,789 | | | Gross Profit | 68,478 | 68,362 | 65,629 | (76,660) | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 62,271 | 66,306 | 68,473 | (75,910) | | Non Recurring |
-
|
-
|
-
|
-
| | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 6,207 | 2,056 | (2,844) | (750) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 1,300 | 544 | 1,204 | 1,417 | | Earnings Before Interest And Taxes | 7,507 | 2,600 | (1,640) | 667 | | Interest Expense |
-
|
-
|
-
| 52 | | Income Before Tax | 7,507 | 2,600 | (1,640) | 615 | | Income Tax Expense | 5,427 | 1,066 | (178) | 1,143 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 2,080 | 1,534 | (1,462) | (528) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 2,080 | 1,534 | (1,462) | (528) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $2,080 | $1,534 | ($1,462) | ($528) |
|
0.22% Nasdaq 
0.24 (3.10%) 
Income Statement
